LIM/10 - Laboratório de Lípides

O Laboratório de Lípides é ligado ao Departamento de Clínica Médica da Faculdade de Medicina da Universidade de São Paulo (FMUSP).

Linhas de pesquisa: investigação do metabolismo de lípedes e lipoproteínas, com ênfase no transporte reverso de colesterol, nas dislipidemias, diabetes mellitus, inflamação e intervenções em estilo de vida (dieta e exercício físico), em humanos e modelos de aterosclerose experimental.

Site oficial: http://limhc.fm.usp.br/portal/lim10-laboratorio-de-lipides/

Navegar

Novos documentos depositados

  1. The Influence of Whey Protein on Muscle Strength, Glycemic Control and Functional Tasks in Older Adults with Type 2 Diabetes Mellitus in a Resistance Exercise Program: Randomized and Triple Blind Clinical Trial

    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, v.20, n.10, article ID 5891, p, 2023

    Objectives: To evaluate the effect of whey protein (WP) supplementation associated with resistance training (RT) on glycemic control, functional tasks, muscle strength, and body composition in older adults living with type 2 diabetes mellitus (T2DM). Secondly, to evaluate the safety of the protoc...

  2. CETP Expression in Bone-Marrow-Derived Cells Reduces the Inflammatory Features of Atherosclerosis in Hypercholesterolemic Mice

    BIOMOLECULES, v.13, n.10, article ID 1556, 12p, 2023

    CETP activity reduces plasma HDL-cholesterol concentrations, a correlate of an increased risk of atherosclerotic events. However, our recent findings suggest that CETP expression in macrophages promotes an intracellular antioxidant state, reduces free cholesterol accumulation and phagocytosis, an...

  3. Down the rabbit hole: reviewing the evidence for primary prevention of cardiovascular disease in people with obesity

    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, v.30, n.17, Special Issue, p.1895-1905, 2023

    Obesity is a prevalent chronic disorder and a well-known risk factor for cardiovascular disease. However, the evidence of treating obesity for primary prevention of major cardiovascular events is still scarce and controversial. In this review, we provided a comprehensive description of the curren...

  4. The impact of obesity in hospitalized patients with COVID-19: a retrospective cohort study

    DIABETOLOGY & METABOLIC SYNDROME, v.16, n.1, article ID 20, 7p, 2024

    Background Obesity is believed to be a risk factor for COVID-19 and unfavorable outcomes, although data on this remains to be better elucidated.Objective To evaluate the impact of obesity on the endpoints of patients hospitalized due to SARS-CoV-2.Methods This retrospective cohort study evaluated...

  5. Coronary Inflammation by Computed Tomography Pericoronary Fat Attenuation and Increased Cytokines in Young Male Anabolic Androgenic Steroid Users

    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, v.120, n.11, article ID e20220822, 8p, 2023

    Background: Anabolic androgenic steroid (AAS) abuse has been associated with coronary artery disease (CAD). Pericoronary fat attenuation (pFA) is a marker of coronary inflammation, which is key in the atherosclerotic process.Objective: To evaluate pFA and inflammatory profile in AAS users.Methods...

  6. Cancer Outcomes Among Prediabetes and Type 2 Diabetes Populations With Dietary and Physical Activity-based Lifestyle Interventions

    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, v.108, n.11, p.E1458-E1459, 2023

  7. Evaluation of oxidative stress in an experimental model of Crohn's disease treated with hyperbaric oxygen therapy

    CLINICS, v.78, article ID 100305, 9p, 2023

    Introduction: Treatments of Inflammatory Bowel Disease (IBD) are able to control symptoms in most cases, how-ever, a fraction of patients do not improve or have a loss of response to treatments, making it important to explore new therapeutic strategies. Hyperbaric oxygen therapy (HBO) may represe...

  8. DIETARY PATTERN OF ELDERLY PEOPLE LIVING IN THE RURAL AREA OF MORTUGABA (BA), BRAZIL

    ATHEROSCLEROSIS, v.379, suppl.1, p.S126-S127, 2023

  9. ADVANCED GLYCATION PRODUCTS MAY BE A GOOD PREDICTOR OF DECREASED COGNITION IN ELDERLY PEOPLE WITH DIABETES

    ATHEROSCLEROSIS, v.379, suppl.1, p.S80-S81, 2023

  10. INCREASED EXPRESSION OF MIR-223-3P AND MIR-375-3P IN HDL TOGETHER WITH A HIGH ANTI-INFLAMMATORY CAPACITY OF HDL IN BREAST CANCER

    ATHEROSCLEROSIS, v.379, suppl.1, p.S61-S61, 2023